FDA Drug Registration Renewal Help & Reactivation
Fix a missed renewal or an inactive drug establishment: why it lapsed, how reactivation works, and how to keep it from happening again.
Key Takeaways
- A missed renewal is fixable — the aim is to restore active status and current listings.
- But it's urgent — lapsed = drugs misbranded (§502(o)) and detained.
- Reactivation = diagnose, correct, resubmit, confirm — then verify "active."
- Listings can be inactivated too — a lapse can drop your NDCs from FDA's directory.
- Most lapses are process failures — untracked window, stale contact, unresponsive registrar.
- Prevent recurrence — move to a tracked, managed annual renewal.
What an "Inactive" Registration Means
Drug establishment registration must be renewed every year (October 1 – December 31). If that window is missed, FDA can treat the registration as inactive/lapsed — and that's not a soft warning state:
- Your drugs are misbranded — under FD&C §502(o), because the establishment isn't currently registered
- Shipments can be refused & detained — at U.S. ports, until it's corrected
- Drug listings can be inactivated — dropping your NDCs out of FDA's directory and downstream systems
- FDA communications may go unanswered — if the contact/U.S. Agent is stale, and the response clock still runs
How Reactivation Works
| Step | What happens |
|---|---|
| 1. Diagnose | Identify why the registration lapsed or is stuck — window, DUNS/FEI, U.S. Agent, or listing issue |
| 2. Correct | Fix the establishment record and re-align the drug listings with it |
| 3. Resubmit | File the corrected registration/listings through FDA's electronic system (SPL/eDRLS) |
| 4. Confirm U.S. Agent | For foreign establishments, verify or replace the U.S. Agent designation |
| 5. Verify active | Confirm the record shows active, then carry it forward so it doesn't lapse again |
Why Renewals Lapse
Most lapses aren't intentional — they're process failures. Knowing the cause is the first step to a clean reactivation and to preventing a repeat:
- Nobody tracked the Oct–Dec window — the single most common cause
- Staff or ownership changed — the reminder went to someone who left
- DUNS/FEI validation errors — blocked the submission from completing
- U.S. Agent not confirmed — leaving a foreign registration incomplete
- Listings drifted out of alignment — with the establishment record
- A prior registrar stopped responding — or only ever filed a one-time registration
Reactivation Isn't Approval — and It Shouldn't Recur
- Reactivation restores registration, not approval — it gets you back to active status; a drug's approval pathway (NDA/ANDA or OTC monograph) is a separate, product-level matter
- Drugs are annual, food is biennial — applying the food (every-two-years) cycle to a drug establishment is a frequent way registrations quietly lapse
- Take over a neglected registration — we can assume, correct, and manage an existing registration from an unresponsive prior registrar
- Prevent recurrence with managed renewal — a tracked annual process that removes the untracked-deadline and stale-contact failure points
Fix a Missed or Inactive Drug Registration
FDA Registration Assistance diagnoses why a registration lapsed or is inactive, corrects the establishment record and drug listings, resubmits through SPL/eDRLS, confirms the U.S. Agent, and restores it to active — then manages the annual renewal going forward so it doesn't recur. We can also take over a neglected registration from a prior registrar.
Contact us at info@fdaregistrationassistance.com or call +1 (928) 275-8333 for a quote. An independent compliance firm serving 1,000+ companies across 135+ countries, with 15+ years of experience.
Frequently Asked Questions — Drug Renewal Help
1. I missed my drug registration renewal - can it be fixed?
Yes, a missed drug establishment registration renewal can be corrected — the goal is to get the establishment back to active status in FDA's system and the listings current. But it's time-sensitive: while the registration is lapsed, your drugs are misbranded under FD&C §502(o) and can be refused or detained at the border. The sooner the record is corrected and resubmitted, the shorter the window in which shipments are at risk.
2. What does an "inactive" drug registration mean?
If a drug establishment doesn't complete its annual renewal (October 1 – December 31), FDA can treat the registration as inactive/lapsed. An inactive registration means the establishment is no longer considered currently registered — so its drugs are misbranded, subject to import refusal and detention, and the associated drug listings can be inactivated (dropping your NDCs out of FDA's directory). It's not a warning state; it's a compliance gap that stops product.
3. How does reactivation work?
Reactivation is a diagnose-correct-resubmit-confirm process: first identify why the registration lapsed or is stuck (missed window, DUNS/FEI validation error, unconfirmed U.S. Agent, listing mismatch, an unresponsive prior registrar); then correct the establishment record and align the drug listings; resubmit through FDA's electronic system (SPL/eDRLS); confirm the U.S. Agent designation; and verify the record shows active. We then carry the registration forward so it doesn't lapse again.
4. Why do drug registration renewals lapse in the first place?
Common causes: nobody tracked the October–December window; a change in staff or ownership meant the reminder went to the wrong person; DUNS or FEI validation errors blocked the submission; the U.S. Agent designation wasn't confirmed; the drug listings drifted out of alignment with the registration; or a previous registrar stopped responding. Most lapses are process failures, not intentional — which is why a managed, tracked renewal prevents them.
5. How urgent is fixing a lapsed registration?
Urgent. Every day the registration is inactive, the establishment's drugs are misbranded and exposed to detention and refusal, and any FDA communications sent to a lapsed/unconfirmed contact can go unanswered. There's no built-in grace period, and reactivation isn't instantaneous — it takes correcting the cause, resubmitting, and waiting for the record to update. Acting quickly minimizes the disruption to shipments and distribution.
6. Does the renewal cover both the registration and the drug listings?
Yes — and both have to be current. Establishment registration is renewed annually (Oct–Dec); drug listings are reviewed and updated (in June and December) whenever information changes, with a "no changes" certification when nothing has. If the registration lapses, the listings tied to it can be inactivated too, so reactivation restores both. For the full annual-renewal rules, see our annual drug renewal guide.
7. Can you take over a registration a previous registrar neglected?
Yes. A frequent reason companies seek renewal help is that their previous registrar became unresponsive, filed only a one-time registration, or didn't manage renewals and listings. We can take over the existing registration, review it for accuracy, correct gaps, reactivate it if it lapsed, and manage it going forward — including the U.S. Agent designation for foreign establishments.
8. How often must drug registration be renewed so this doesn't recur?
Annually, between October 1 and December 31 (21 CFR 207.29) — drug registration is annual, unlike food facility registration, which is biennial. Applying the food (every-two-years) cycle to a drug establishment is a common way registrations quietly lapse. A managed renewal that tracks the annual window and keeps listings aligned prevents a repeat.
9. Will a lapse affect my drug listings and NDCs?
It can. FDA periodically inactivates drug listings tied to establishments that aren't currently registered or that missed required certifications — which removes those NDCs from FDA's directory. That can affect not just imports but downstream systems that rely on the NDC (reimbursement, retail/marketplace listings). Reactivation restores the registration and re-aligns the listings so the NDCs are valid again.
10. Do foreign establishments have extra steps to reactivate?
Foreign drug establishments must confirm a valid U.S. Agent as part of a valid registration, so reactivation includes verifying (or replacing) the U.S. Agent designation. A lapsed or unconfirmed U.S. Agent is itself a common reason a foreign registration is treated as incomplete, so it's one of the first things to check when reactivating.
11. Does reactivating my registration make my drug approved?
No. Reactivation only restores your establishment's active registration status — it is not FDA approval. Registration identifies your facility; approval (NDA/ANDA, or OTC monograph compliance) is a separate, product-level status. Reactivation gets you back to a valid registration; it doesn't change or confer a product's approval pathway.
12. What information do you need to help with a renewal or reactivation?
Generally your establishment's legal name and address, any existing FDA registration number/FEI and DUNS, the current registration and listing status, your product/NDC information, and (for foreign establishments) U.S. Agent details. With that we can assess what lapsed or is misaligned, correct it, and resubmit to bring the registration and listings back to active.
13. How can I prevent this from happening again?
Move to a managed renewal: a partner that tracks the October–December window, verifies your facility/DUNS/FEI and U.S. Agent details each cycle, keeps the drug listings aligned, files the SPL renewal, and confirms the active status — year after year. Most lapses come from an untracked deadline or a stale contact; a managed process removes both failure points.
14. How does FDA Registration Assistance help with drug renewal and reactivation?
We diagnose why a registration lapsed or is inactive, correct the establishment record and drug listings, resubmit through SPL/eDRLS, confirm the U.S. Agent, and restore the registration to active — then manage the annual renewal going forward so it doesn't recur. We can also take over a neglected registration from a prior registrar. We're an independent compliance firm serving 1,000+ companies across 135+ countries over 15+ years. Contact info@fdaregistrationassistance.com or +1 (928) 275-8333.
